Noho Inc (DRNK) financial statements (2021 and earlier)
Company profile
| Business Address |
8340 E. RAINTREE DR., UNIT D SCOTTDALE, AZ 85260 |
| State of Incorp. | WY |
| Fiscal Year End | December 31 |
| SIC | 2833 - Medicinal Chemicals and Botanical Products (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in thousands)
| 12/31/2013 | |||
|---|---|---|---|
| ASSETS | |||
| Current Assets | |||
| Cash, cash equivalents, and short-term investments | 19 | ||
| Cash and cash equivalents | 19 | ||
| Other current assets | 13 | ||
| Total current assets: | 32 | ||
| Noncurrent Assets | |||
| Property, plant and equipment | 19 | ||
| Total noncurrent assets: | 19 | ||
| TOTAL ASSETS: | 51 | ||
| LIABILITIES AND EQUITY | |||
| Liabilities | |||
| Current Liabilities | |||
| Noncurrent Liabilities | |||
| Stockholders' equity | |||
Income statement (P&L) ($ in thousands)
| 12/31/2013 | ||
|---|---|---|
| Operating expenses | (80) | |
| Operating loss: | (80) | |
| Net loss: | (80) | |
| Other undisclosed net loss attributable to parent | (2,706) | |
| Net loss available to common stockholders, diluted: | (2,787) | |
Comprehensive Income ($ in thousands)
| 12/31/2013 | ||
|---|---|---|
| Net loss: | (80) | |
| Comprehensive loss, net of tax, attributable to parent: | (80) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.